Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 92
Filter
1.
Parasitology ; 147(13): 1425-1432, 2020 11.
Article in English | MEDLINE | ID: mdl-32729453

ABSTRACT

In this study, we evaluated the efficacy, expressed as a mean weight decrease of the whole echinococcal cyst mass, of novel benzimidazole salt formulations in a murine Echinococcus granulosus infection model. BALB/c mice were intraperitoneally infected with protoscoleces of E. granulosus (genotype G1). At 9 months post-infection, treatment with albendazole (ABZ), ricobendazole (RBZ) salt formulations, and RBZ enantiomer salts (R)-(+)-RBZ-Na and (S)-(-)-RBZ-Na formulations were initiated. Drugs were orally applied by gavage at 10 mg kg-1 body weight per day during 30 days. Experimental treatments with benzimidazole sodium salts resulted in a significant reduction of the weight of cysts compared to conventional ABZ treatment, except for the (S)-(-)-RBZ-Na enantiomer formulation. Scanning electron microscopy and histological inspection revealed that treatments impacted not only the structural integrity of the parasite tissue in the germinal layer, but also induced alterations in the laminated layer. Overall, these results demonstrate the improved efficacy of benzimidazole salt formulations compared to conventional ABZ treatment in experimental murine cystic echinococcosis.


Subject(s)
Albendazole/administration & dosage , Anticestodal Agents/administration & dosage , Echinococcosis/drug therapy , Echinococcus granulosus/drug effects , Albendazole/analogs & derivatives , Animals , Female , Mice , Mice, Inbred BALB C , Salts/chemistry
2.
Parasitology ; 146(2): 187-196, 2019 02.
Article in English | MEDLINE | ID: mdl-30113011

ABSTRACT

This is the first report on the development and characterization of eight monoclonal antibodies (MABs) generated against whole- and membrane-enriched tachyzoite extracts of the apicomplexan parasite Besnoitia besnoiti. Confocal laser scanning immunofluorescence microscopy was used to localize respective epitopes in B. besnoiti tachyzoites along the lytic cycle. A pattern compatible with dense granule staining was observed with MABs 2.A.12, 2.F.3 and 2.G.4, which could be confirmed by immunogold electron microscopy for MABs 2.A.12 and 2.F.3. In particular, MABs 2.F.3 and 2.G.4 were secreted during early invasion, proliferation and egress phases. MABs 3.10.8 and 5.5.11 labelled the tachyzoite surface, whilst MABs 1.17.8, 8.9.2 and 2.G.A recognized the apical tip, which is reminiscent for microneme localization. Besides, the epitopes recognized by the latter two (MABs 8.9.2 and 2.G.A) exhibited a redistribution from the anterior part across the parasite surface towards the posterior end during invasion. Most MABs developed were genus-specific. Indeed, the MABs cross-reacted neither with T. gondii nor with N. caninum tachyzoites. In summary, we have generated MABs that will be useful to study the key processes in the lytic cycle of the parasite and with additional promising diagnostic value. However, the molecular identity of the antigens recognized remains to be elucidated.


Subject(s)
Antibodies, Monoclonal/biosynthesis , Antibodies, Monoclonal/immunology , Sarcocystidae/immunology , Animals , Biomarkers , Blotting, Western , Electrophoresis, Polyacrylamide Gel , Epitopes/biosynthesis , Epitopes/immunology , Hybridomas/immunology , Immunohistochemistry , Mice , Mice, Inbred BALB C , Microscopy, Confocal , Microscopy, Electron, Transmission , Sarcocystidae/ultrastructure
3.
Schweiz Arch Tierheilkd ; 160(6): 363-374, 2018 Jun.
Article in German | MEDLINE | ID: mdl-29905160

ABSTRACT

INTRODUCTION: Diarrhea in calves is one of the most important cattle diseases in Switzerland. The diagnosis and treatment of calf diarrhea represent a major challenge. Single-celled Cryptosporidium parasites are the most prevalent causative agents of calf diarrhea besides rotavirus in the first weeks of life, and are responsible for about 50% of diarrheal cases. Cryptosporidium parvum has been described as a cause of diarrhea in one to three weeks old calves since the 1970s. Oral ingestion of persistent environmental oocysts results in severe diarrhea lasting four to six days and shedding of large numbers of infectious oocysts. A tiny amount of 10 oocysts is already sufficient to cause disease. Detailed knowledge about the epidemiology and virulence of the different C. parvum strains is still lacking. In addition, current diagnostic tests cannot reliably distinguish between non-pathogenic (e.g. C. bovis) and pathogenic Cryptosporidium species. Until now, no effective therapeutic drug or vaccine against calf cryptosporidiosis has been found. Water-borne epidemics and the zoonotic potential of Cryptosporidium in immunodeficient patients are of great medical importance. The increasing number of cryptosporidiosis cases associated with high infant mortality in less industrialized and impoverished regions (including South-East Asia and sub-Saharan Africa) has intensified the research in recent years. The recent discoveries of new therapeutics against C. parvum may benefit calf medicine in the near future. This review article reports on these new developments, highlights calf cryptosporidiosis in Switzerland and draws attention to a new research project.


INTRODUCTION: La diarrhée chez les veaux est l'une des maladies du bétail les plus courantes en Suisse. Le diagnostic de la cause et le traitement de la diarrhée des veaux représentent un défi majeur. En Suisse, les cryptosporidies sont, avec les rotavirus, l'agent causal le plus fréquent de diarrhée du veau dans les premières semaines et elles sont responsables d'environ 50% des cas. Le parasite unicellulaire Cryptosporidium parvum a été décrit depuis les années 1970 comme un agent de diarrhée chez les veaux d'une à trois semaines. Après ingestion orale d'oocystes persistants dans l'environnement, il se produit après quelques jours une diarrhée sévère de quatre à six jours avec excrétion massive d'oocystes déjà infectieux. Même quelques oocystes persistants dans l'environnement peuvent être pathogènes. Du point de vue épidémiologique, il existe encore de grandes lacunes dans la connaissance de la variabilité suspectée dans la virulence de diverses souches de C. parvum. En outre, des espèces non pathogènes (entre autres Cryptosporidium bovis) peuvent être présentes chez les veaux, qui ne se distinguent pas de C. parvum avec les tests diagnostiques actuels. Jusqu'à présent, aucun médicament efficace sur le plan thérapeutique et aucun vaccin contre la cryptosporidiose du veau n'ont été trouvés. En médecine humaine, les épidémies transmises par l'eau (en particulier aux États-Unis) et l'importance zoonotique des cryptosporidies comme pathogènes opportunistes chez les personnes immunodéficientes jouent un rôle de premier plan. La forte morbidité de la cryptosporidiose associée à une forte mortalité infantile dans les régions les moins industrialisées et les plus pauvres (entre autres en Asie du Sud-Est et en Afrique subsaharienne) ont relancé la recherche sur ces parasites au cours des dernières années. En particulier, la découverte de nouveaux médicaments contre C. parvum est susceptible de bénéficier à la médecine du veau dans un proche avenir. Cet article de synthèse fait le point sur ces nouveaux développements mais surtout sur la cryptosporidiose du veau en Suisse et attire l'attention sur un nouveau projet de recherche.


Subject(s)
Cattle Diseases/physiopathology , Cattle Diseases/parasitology , Cryptosporidiosis/physiopathology , Cryptosporidium parvum/isolation & purification , Diarrhea/veterinary , Animals , Cattle , Cryptosporidiosis/parasitology , Diarrhea/parasitology , Diarrhea/physiopathology , Switzerland , Veterinary Medicine
4.
Parasitology ; 144(7): 937-944, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28270242

ABSTRACT

Alveolar echinococcosis (AE) is an emerging zoonotic disease caused by the cestode Echinococcus multilocularis. The secondary infection model of AE is based on intraperitoneal injection of disease-causing metacestodes into the peritoneal cavity of mice, which allows investigations on novel drugs or immunotherapeutical treatment options in vivo. So far, such in vivo studies assessed exclusively the parasite weight at the endpoint of a given treatment period. We here developed an ultrasound (US)-based scoring system that allows to follow-up parasite development in the living animal, and provides insights into parasite growth during the treatment phase. By this method a statistically significant difference between untreated and medicated mice with E. multilocularis infection was observed at 2 months post-infection, and the growth curve of the parasite load was described by a linear mixed model. High correlation and similar levels of variation were observed for the standard method based on parasite weight measurement, the novel US-based scoring system, as well volume segmentation by post-mortem magnetic resonance imaging. Thus, US-based scoring in the live animal has the potential to assist the 3R concept by contributing to the refinement and reduction of animal use in experimental echinococcosis.


Subject(s)
Anticestodal Agents/pharmacology , Echinococcosis/diagnostic imaging , Echinococcus multilocularis/drug effects , Magnetic Resonance Imaging , Parasite Load/methods , Ultrasonography , Albendazole/pharmacology , Animals , Disease Models, Animal , Female , Mefloquine/pharmacology , Mice , Mice, Inbred BALB C
5.
PLoS One ; 11(12): e0168228, 2016.
Article in English | MEDLINE | ID: mdl-27936156

ABSTRACT

Neurological disorders in ruminants have an important impact on veterinary health, but very few host-specific in vitro models have been established to study diseases affecting the nervous system. Here we describe a primary neuronal dorsal root ganglia (DRG) culture derived from calves after being conventionally slaughtered for food consumption. The study focuses on the in vitro characterization of bovine DRG cell populations by immunofluorescence analysis. The effects of various growth factors on neuron viability, neurite outgrowth and arborisation were evaluated by morphological analysis. Bovine DRG neurons are able to survive for more than 4 weeks in culture. GF supplementation is not required for neuronal survival and neurite outgrowth. However, exogenously added growth factors promote neurite outgrowth. DRG cultures from regularly slaughtered calves represent a promising and sustainable host specific model for the investigation of pain and neurological diseases in bovines.


Subject(s)
Ganglia, Spinal/pathology , Animals , Cattle , Cells, Cultured , Coculture Techniques , Microscopy, Electron, Transmission
6.
Parasite Immunol ; 38(12): 709-723, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27314818

ABSTRACT

Bovine neosporosis is a worldwide concern due to its global distribution and great economic impact. Reproductive failure in cattle due to abortion leads to major economic losses associated with the disease. Currently, there is no treatment or vaccine available against abortion or transmission caused by Neospora caninum infection in cattle. However, vaccination is considered the best measure of control against bovine neosporosis. Several host and parasite factors can influence the dynamics of the infection in bovines. Moreover, the availability of well-defined infection models is a key factor for the evaluation of vaccine candidates. However, working with cattle is not easy due to difficult handling, facilities and costs, and therefore, 'more affordable' models could be used for screening of promising vaccines to establish proof of concept. So far, live-attenuated vaccines have shown good efficacy against exogenous transplacental transmission; however, they have relevant disadvantages and associated risks, which render inactivated or subunit vaccines the best way forward. The identification of novel potential targets and vaccines, and the application of innovative vaccine technologies in harmonized experimental animal models, will accelerate the development of an effective vaccine against bovine neosporosis.


Subject(s)
Cattle Diseases/prevention & control , Coccidiosis/veterinary , Neospora/immunology , Protozoan Vaccines/immunology , Vaccination/veterinary , Animals , Cattle , Cattle Diseases/immunology , Cattle Diseases/parasitology , Coccidiosis/immunology , Coccidiosis/parasitology , Coccidiosis/prevention & control , Disease Models, Animal , Vaccines, Attenuated/immunology
7.
Parasitology ; 140(8): 929-51, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23561006

ABSTRACT

Parasitic protozoa comprise diverse aetiological agents responsible for important diseases in humans and animals including sleeping sickness, Chagas disease, leishmaniasis, malaria, toxoplasmosis and others. They are major causes of mortality and morbidity in tropical and subtropical countries, and are also responsible for important economic losses. However, up to now, for most of these parasitic diseases, effective vaccines are lacking and the approved chemotherapeutic compounds present high toxicity, increasing resistance, limited efficacy and require long periods of treatment. Many of these parasitic illnesses predominantly affect low-income populations of developing countries for which new pharmaceutical alternatives are urgently needed. Thus, very low research funding is available. Amidine-containing compounds such as pentamidine are DNA minor groove binders with a broad spectrum of activities against human and veterinary pathogens. Due to their promising microbicidal activity but their rather poor bioavailability and high toxicity, many analogues and derivatives, including pro-drugs, have been synthesized and screened in vitro and in vivo in order to improve their selectivity and pharmacological properties. This review summarizes the knowledge on amidines and analogues with respect to their synthesis, pharmacological profile, mechanistic and biological effects upon a range of intracellular protozoan parasites. The bulk of these data may contribute to the future design and structure optimization of new aromatic dicationic compounds as novel antiparasitic drug candidates.


Subject(s)
Amidines/pharmacology , Antiprotozoal Agents/pharmacology , Parasites/drug effects , Protozoan Infections/drug therapy , Amidines/chemical synthesis , Amidines/chemistry , Amidines/pharmacokinetics , Animals , Antiprotozoal Agents/chemical synthesis , Antiprotozoal Agents/chemistry , Antiprotozoal Agents/pharmacokinetics , Humans , Intracellular Space/diagnostic imaging , Intracellular Space/parasitology , Microscopy, Electron, Transmission , Parasites/ultrastructure , Pentamidine/analogs & derivatives , Pentamidine/chemistry , Pentamidine/pharmacology , Protozoan Infections/parasitology , Ultrasonography
8.
Med Microbiol Immunol ; 202(3): 197-206, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23269418

ABSTRACT

Mesenchymal stromal cells (MSCs) have a multilineage differentiation potential and provide immunosuppressive and antimicrobial functions. Murine as well as human MSCs restrict the proliferation of T cells. However, species-specific differences in the underlying molecular mechanisms have been described. Here, we analyzed the antiparasitic effector mechanisms active in murine MSCs. Murine MSCs, in contrast to human MSCs, could not restrict the growth of a highly virulent strain of Toxoplasma gondii (BK) after stimulation with IFN-γ. However, the growth of a type II strain of T. gondii (ME49) was strongly inhibited by IFN-γ-activated murine MSCs. Immunity-related GTPases (IRGs) as well as guanylate-binding proteins (GBPs) contributed to this antiparasitic effect. Further analysis showed that IFN-γ-activated mMSCs also inhibit the growth of Neospora caninum, a parasite belonging to the apicomplexan group as well. Detailed studies with murine IFN-γ-activated MSC indicated an involvement in IRGs like Irga6, Irgb6 and Irgd in the inhibition of N. caninum. Additional data showed that, furthermore, GBPs like mGBP1 and mGBP2 could have played a role in the anti-N. caninum effect of murine MSCs. These data underline that MSCs, in addition to their regenerative and immunosuppressive activity, function as antiparasitic effector cells as well. However, IRGs are not present in the human genome, indicating a species-specific difference in anti-T. gondii and anti-N. caninum effect between human and murine MSCs.


Subject(s)
GTP Phosphohydrolases/metabolism , GTP-Binding Proteins/immunology , GTP-Binding Proteins/metabolism , Mesenchymal Stem Cells/enzymology , Mesenchymal Stem Cells/immunology , Neospora/immunology , Toxoplasma/immunology , Animals , Interferon-gamma/metabolism , Mice , Neospora/growth & development , Toxoplasma/growth & development
9.
Parasite Immunol ; 35(1): 11-20, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23046358

ABSTRACT

In this study, mice were vaccinated intranasally with recombinant N. caninum protein disulphide isomerase (NcPDI) emulsified in cholera toxin (CT) or cholera toxin subunit B (CTB) from Vibrio cholerae. The effects of vaccination were assessed in the murine nonpregnant model and the foetal infection model, respectively. In the nonpregnant mice, previous results were confirmed, in that intranasal vaccination with recNcPDI in CT was highly protective, and low cerebral parasite loads were noted upon real-time PCR analysis. Protection was accompanied by an IgG1-biased anti-NcPDI response upon infection and significantly increased expression of Th2 (IL-4/IL-10) and IL-17 transcripts in spleen compared with corresponding values in mice treated with CT only. However, vaccination with recNcPDI in CT did not induce significant protection in dams and their offspring. In the dams, increased splenic Th1 (IFN-γ/IL-12) and Th17 mRNA expressions was detected. No protection was noted in the groups vaccinated with recNcPDI emulsified in CTB. Thus, vaccination with recNcPDI in CT in nonpregnant mice followed by challenge infection induced a protective Th2-biased immune response, while in the pregnant mouse model, the same vaccine formulation resulted in a Th1-biased inflammatory response and failed to protect dams and their progeny.


Subject(s)
Coccidiosis/immunology , Neospora/physiology , Protozoan Vaccines/administration & dosage , Administration, Intranasal , Animals , Antigens, Protozoan/immunology , Brain/parasitology , Coccidiosis/parasitology , Cytokines/genetics , Cytokines/immunology , Disease Models, Animal , Female , Immunity, Humoral , Lung/parasitology , Mice , Mice, Inbred BALB C , Parasite Load , Protozoan Vaccines/immunology , Spleen/immunology , T-Lymphocyte Subsets/immunology
10.
Oncogene ; 31(37): 4095-106, 2012 Sep 13.
Article in English | MEDLINE | ID: mdl-22158036

ABSTRACT

Glutathione-S-transferase of the Pi class (GSTP1) is frequently overexpressed in a variety of solid tumors and has been identified as a potential therapeutic target for cancer therapy. GSTP1 is a phase II detoxification enzyme and conjugates the tripeptide glutathione to endogenous metabolites and xenobiotics, thereby limiting the efficacy of antitumor chemotherapeutic treatments. In addition, GSTP1 regulates cellular stress responses and apoptosis by sequestering and inactivating c-Jun N-terminal kinase (JNK). Thiazolides are a novel class of antibiotics for the treatment of intestinal pathogens with no apparent side effects on the host cells and tissue. Here we show that thiazolides induce a GSTP1-dependent and glutathione-enhanced cell death in colorectal tumor cell lines. Downregulation of GSTP1 reduced the apoptotic activity of thiazolides, whereas overexpression enhanced it. Thiazolide treatment caused strong Jun kinase activation and Jun kinase-dependent apoptosis. As a critical downstream target of Jun kinase we identified the pro-apoptotic Bcl-2 homolog Bim. Thiazolides induced Bim expression and activation in a JNK-dependent manner. Downregulation of Bim in turn significantly blocked thiazolide-induced apoptosis. Whereas low concentrations of thiazolides failed to induce apoptosis directly, they potently sensitized colon cancer cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic drug-induced cell death. Although GSTP1 overexpression generally limits chemotherapy and thus antitumor treatment, our study identifies GSTP1 as Achilles' heel and thiazolides as novel interesting apoptosis sensitizer for the treatment of colorectal tumors.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis Regulatory Proteins/metabolism , Apoptosis , Benzamides/pharmacology , Colorectal Neoplasms/metabolism , Glutathione S-Transferase pi/metabolism , JNK Mitogen-Activated Protein Kinases/metabolism , Membrane Proteins/metabolism , Proto-Oncogene Proteins/metabolism , Thiazoles/pharmacology , Apoptosis Regulatory Proteins/genetics , Bcl-2-Like Protein 11 , Caco-2 Cells , Cell Line, Tumor , Down-Regulation , Humans , MAP Kinase Signaling System , Membrane Proteins/genetics , Mitochondria/metabolism , Proto-Oncogene Proteins/genetics , RNA Interference , RNA, Small Interfering , TNF-Related Apoptosis-Inducing Ligand/metabolism
11.
J Proteomics ; 74(5): 629-42, 2011 May 01.
Article in English | MEDLINE | ID: mdl-21315855

ABSTRACT

Apicomplexan parasites possess an apical complex that is composed of two secretory organelles recognized as micronemes and rhoptries. Rhoptry contents are secreted into the parasitophorous vacuole during the host cell invasion process. Several rhoptry proteins have been identified in Toxoplasma gondii and seem to be involved in host-pathogen interactions and some of them are considered to be important virulence factors. Only one rhoptry protein, NcROP2, has been identified and extensively characterized in the closely related parasite Neospora caninum, and this has showed immunoprotective properties. Thus, with the aim of increasing knowledge of the rhoptry protein repertoire in N. caninum, a subcellular fractionation of tachyzoites was performed to obtain fractions enriched for this secretory organelle. 2-D SDS-PAGE followed by MS and LC/MS-MS were applied for fraction analysis and 8 potential novel rhoptry components (NcROP1, 5, 8, 30 and NcRON2, 3, 4, 8) and several kinases, proteases and phosphatases proteins were identified with a high homology to those previously found in T. gondii. Their existence in N. caninum tachyzoites suggests their involvement in similar events or pathways that occur in T. gondii. These novel proteins may be considered as targets that could be useful in the future development of immunoprophylactic measures.


Subject(s)
Membrane Proteins/metabolism , Neospora/metabolism , Virulence Factors/metabolism , Mass Spectrometry/methods , Membrane Proteins/analysis , Subcellular Fractions/metabolism , Toxoplasma/metabolism
12.
Parasitology ; 138(5): 583-92, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21349220

ABSTRACT

The in vitro effects of 4 arylimidamides (DB811, DB786, DB750 and DB766) against the proliferative tachyzoite stage of the apicomplexan parasite Besnoitia besnoiti were investigated. These four compounds had been shown earlier to exhibit in vitro activities in the nanomolar range against the related apicomplexans Neospora caninum and Toxoplasma gondii. Real-time-PCR was used to assess B. besnoiti intracellular proliferation in vitro. Preliminary assessment by light microscopy identified DB811 and DB750 as the most promising compounds, while DB786 and DB766 were much less effective. Three-day-growth assays and quantitative real-time PCR was used for IC50 determination of DB811 (0.079 µM) and DB750 (0.56 µM). Complete growth inhibition was observed at 1.6 µM for DB 811 and 1.7 µM for DB750. However, when infected cultures were treated for 14 days, proliferation of parasites occurred again in cultures treated with DB750 from day 4 onwards, while the proliferation of DB811-treated tachyzoites remained inhibited. Electron microscopy of B. besnoiti-infected fibroblast cultures fixed and processed at different time-points following the initiation of drug treatments revealed that DB811 exerted a much higher degree of ultrastructural alterations compared to DB750. These results show that arylimidamides such as DB811 could potentially become an important addition to the anti-parasitic arsenal for food animal production, especially in cattle.


Subject(s)
Acrylamides/pharmacology , Amides/pharmacology , Antiprotozoal Agents/pharmacology , Cattle Diseases/parasitology , Coccidiosis/veterinary , Sarcocystidae/drug effects , Acrylamides/chemistry , Amides/chemistry , Amidines/chemistry , Amidines/pharmacology , Animals , Antiprotozoal Agents/chemistry , Cattle , Chlorocebus aethiops , Coccidiosis/parasitology , Fibroblasts/drug effects , Fibroblasts/parasitology , Furans/chemistry , Furans/pharmacology , Humans , Inhibitory Concentration 50 , Microscopy, Electron , Parasitic Sensitivity Tests/methods , Parasitic Sensitivity Tests/veterinary , Polymerase Chain Reaction/methods , Polymerase Chain Reaction/veterinary , Sarcocystidae/pathogenicity , Sarcocystidae/ultrastructure , Time Factors , Vero Cells
13.
Parasite Immunol ; 33(2): 81-94, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21226721

ABSTRACT

The effects of nanogel encapsulation of recombinant NcPDI (recNcPDI) following vaccination of mice by intranasal or intraperitoneal routes and challenge infection with Neospora caninum tachyzoites were investigated. Nanogels were chitosan based, with an alginate or alginate-mannose surface. None of the mice receiving recNcPDI intraperitoneal (i.p.) (without nanogels) survived, whereas intranasal (i.n.) application protected 9 of 10 mice from disease. Association of recNcPDI with nanogels improved survival of i.p. vaccinated mice, but nanogels without recNcPDI gave similar protection levels. When nanogels were inoculated via the i.n. route, 80% of the mice were protected. Association of recNcPDI with the alginate-coated nanogels protected all mice against disease. Quantification of the cerebral parasite burden showed a significant reduction of parasite numbers in most experimental groups vaccinated i.n., except those vaccinated with alginate-mannose nanogels with or without recNcPDI. For i.p. vaccinated groups, no significant differences in cerebral infection densities were measured, but there was a reduction in the groups vaccinated with recNcPDI associated with both types of nanogels. Analysis of the immune responses of infected mice indicated that association of recNcPDI with nanogels altered the patterns of cytokine mRNA expression profiles, but had no major impact on the antibody subtype responses. Nevertheless, this did not necessarily relate to the protection.


Subject(s)
Chitosan/administration & dosage , Coccidiosis/prevention & control , Drug Carriers/administration & dosage , Neospora/immunology , Polyethylene Glycols/administration & dosage , Polyethyleneimine/administration & dosage , Protein Disulfide-Isomerases/immunology , Protozoan Vaccines/immunology , Administration, Intranasal , Animals , Brain/parasitology , Coccidiosis/immunology , Disease Models, Animal , Female , Injections, Intraperitoneal , Mice , Mice, Inbred BALB C , Nanogels , Neospora/enzymology , Protein Disulfide-Isomerases/administration & dosage , Protozoan Vaccines/administration & dosage , Survival Analysis , Vaccination/methods , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/immunology
15.
Parasitology ; 137(3): 569-87, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19765346

ABSTRACT

Among the cestodes, Echinococcus granulosus, Echinococcus multilocularis and Taenia solium represent the most dangerous parasites. Their larval stages cause the diseases cystic echinococcosis (CE), alveolar echinococcosis (AE) and cysticercosis, respectively, which exhibit considerable medical and veterinary health concerns with a profound economic impact. Others caused by other cestodes, such as species of the genera Mesocestoides and Hymenolepis, are relatively rare in humans. In this review, we will focus on E. granulosus and E. multilocularis metacestode laboratory models and will review the use of these models in the search for novel drugs that could be employed for chemotherapeutic treatment of echinococcosis. Clearly, improved therapeutic drugs are needed for the treatment of AE and CE, and this can only be achieved through the development of medium-to-high throughput screening approaches. The most recent achievements in the in vitro culture and genetic manipulation of E. multilocularis cells and metacestodes, and the accessability of the E. multilocularis genome and EST sequence information, have rendered the E. multilocularis model uniquely suited for studies on drug-efficacy and drug target identification. This could lead to the development of novel compounds for the use in chemotherapy against echinococcosis, and possibly against diseases caused by other cestodes, and potentially also trematodes.


Subject(s)
Anthelmintics/pharmacology , Echinococcus/drug effects , Trematoda/drug effects , Animals , Drug Evaluation, Preclinical
16.
Parasitology ; 137(2): 229-40, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19835644

ABSTRACT

Recombinant NcPDI(recNcPDI), NcROP2(recNcROP2), and NcMAG1(recNcMAG1) were expressed in Escherichia coli and purified, and evaluated as potential vaccine candidates by employing the C57Bl/6 mouse cerebral infection model. Intraperitoneal application of these proteins suspended in saponin adjuvants lead to protection against disease in 50% and 70% of mice vaccinated with recNcMAG1 and recNcROP2, respectively, while only 20% of mice vaccinated with recNcPDI remained without clinical signs. In contrast, a 90% protection rate was achieved following intra-nasal vaccination with recNcPDI emulsified in cholera toxin. Only 1 mouse vaccinated intra-nasally with recNcMAG1 survived the challenge infection, and protection achieved with intra-nasally applied recNcROP2 was at 60%. Determination of cerebral parasite burdens by real-time PCR showed that these were significantly reduced only in recNcROP2-vaccinated animals (following intraperitoneal and intra-nasal application) and in recNcPDI-vaccinated mice (intra-nasal application only). Quantification of viable tachyzoites in brain tissue of intra-nasally vaccinated mice showed that immunization with recNcPDI resulted in significantly decreased numbers of live parasites. These data show that, besides the nature of the antigen, the protective effect of vaccination also depends largely on the route of antigen delivery. In the case of recNcPDI, the intra-nasal route provides a platform to generate a highly protective immune response.


Subject(s)
Antigens, Protozoan , Brain Diseases/prevention & control , Coccidiosis/prevention & control , Neospora/immunology , Protozoan Vaccines , Recombinant Proteins , Administration, Intranasal , Animals , Antibodies, Protozoan/blood , Antigens, Protozoan/administration & dosage , Antigens, Protozoan/genetics , Antigens, Protozoan/immunology , Brain/immunology , Brain/parasitology , Brain Diseases/immunology , Brain Diseases/parasitology , Coccidiosis/immunology , Coccidiosis/parasitology , Disease Models, Animal , Female , Injections, Intraperitoneal , Mice , Mice, Inbred C57BL , Neospora/growth & development , Neospora/pathogenicity , Protozoan Vaccines/administration & dosage , Protozoan Vaccines/genetics , Protozoan Vaccines/immunology , Recombinant Proteins/administration & dosage , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Vaccination/methods
17.
Parasitology ; 137(3): 557-68, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19961650

ABSTRACT

As more facts emerge regarding the ways in which E. multilocularis-derived molecules trigger the host immune response and modulate the host-parasite interplay, it becomes possible to envisage how the parasite can survive and proliferate in its intermediate host, while in other hosts it dies out. Through effects on cells of both the innate and adaptive arms of the immune response, E. multilocularis can orchestrate a range of outcomes that are beneficial not only to the parasite, in terms of facilitating its intrahepatic proliferation and maturation, and thus life cycle over all, but also to its intermediate host, in limiting pathology. The present review deals with the role of metacestode surface molecules as well as excretory/secretory (E/S) metabolic products of the parasite in the modulation of the host responses such as to optimize its own survival.


Subject(s)
Echinococcosis, Hepatic/parasitology , Echinococcus multilocularis/physiology , Animals , Host-Parasite Interactions , Humans
18.
Cytogenet Genome Res ; 125(3): 165-75, 2009.
Article in English | MEDLINE | ID: mdl-19738377

ABSTRACT

The Bloom protein (BLM) and Topoisomerase IIIalpha are found in association with proteins of the Fanconi anemia (FA) pathway, a disorder manifesting increased cellular sensitivity to DNA crosslinking agents. In order to determine if the association reflects a functional interaction for the maintenance of genome stability, we have analyzed the effects of siRNA-mediated depletion of the proteins in human cells. Depletion of Topoisomerase IIIalpha or BLM leads to increased radial formation, as is seen in FA. BLM and Topoisomerase IIIalpha are epistatic to the FA pathway for suppression of radial formation in response to DNA interstrand crosslinks since depletion of either of them in FA cells does not increase radial formation. Depletion of Topoisomerase IIIalpha or BLM also causes an increase in sister chromatid exchanges, as is seen in Bloom syndrome cells. Human Fanconi anemia cells, however, do not demonstrate increased sister chromatid exchanges, separating this response from radial formation. Primary cell lines from mice defective in both Blm and Fancd2 have the same interstrand crosslink-induced genome instability as cells from mice deficient in the Fancd2 protein alone. These observations demonstrate that the association of BLM and Topoisomerase IIIalpha with Fanconi proteins is a functional one, delineating a BLM-Topoisomerase IIIalpha-Fanconi pathway that is critical for suppression of chromosome radial formation.


Subject(s)
DNA Topoisomerases, Type I/metabolism , DNA/metabolism , Fanconi Anemia/metabolism , RecQ Helicases/metabolism , Animals , Cell Line , Cross-Linking Reagents/pharmacology , DNA Topoisomerases, Type I/genetics , Fanconi Anemia/genetics , Genomic Instability/drug effects , Humans , Mice , Mice, Inbred C57BL , Mice, Knockout , Mitomycin/pharmacology , RNA, Small Interfering/genetics , RecQ Helicases/genetics , Sister Chromatid Exchange
19.
Parasite Immunol ; 31(7): 366-72, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19527452

ABSTRACT

Dendritic cells (DCs) represent the first line defence of the innate immune system following infection with pathogens. We exploratively addressed invasion and survival ability of Neospora caninum, a parasite causing abortion in cattle, in mouse bone marrow DCs (BMDCs), and respective cytokine expression patterns. Immature BMDCs were exposed to viable (untreated) and nonviable parasites that had been inactivated by different means. Invasion and/or internalization, as well as intracellular survival and proliferation of tachyzoites were determined by NcGRA2-RT-PCR and transmission electron microscopy (TEM). Cytokine expression was evaluated by reverse transcription (RT)-PCR and cytokine ELISA. Transmission electron microscopy of DCs stimulated with untreated viable parasites revealed that N. caninum was able to invade and proliferate within BMDCs. This was confirmed by NcGRA2-RT-PCR. On the other hand, no viable parasite organisms were revealed by TEM when exposing BMDCs to inactivated parasites (nonviability demonstrated by NcGRA2-RT-PCR). Cytokine expression analysis (as assessed by both RT-PCR and ELISA) demonstrated that both viable and nonviable parasites stimulated mBMDCs to express IL-12p40, IL-10 and TNF-alpha, whereas IL-4 RNA expression was not detected. Thus, exposure of mBMDCs to both viable and nonviable parasites results in the expression of cytokines that are relevant for a mixed Th1/Th2 immune response.


Subject(s)
Cytokines/biosynthesis , Dendritic Cells/immunology , Dendritic Cells/parasitology , Microbial Viability , Neospora/growth & development , Neospora/immunology , Animals , Cells, Cultured , Cytosol/parasitology , Enzyme-Linked Immunosorbent Assay/methods , Mice , Mice, Inbred C57BL , Microscopy, Electron, Transmission/methods , Reverse Transcriptase Polymerase Chain Reaction/methods
20.
J Helminthol ; 83(2): 99-111, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19296876

ABSTRACT

Echinococcus granulosus and Echinococcus multilocularis are cestode parasites, of which the metacestode (larval) stages cause the neglected diseases cystic echinococcosis (CE) and alveolar echinococcosis (AE), respectively. The benzimidazoles albendazole and mebendazole are presently used for the chemotherapeutical treatment, alone or prior to and after surgery. However, in AE these benzimidazoles do not appear to be parasiticidal in vivo. In addition, failures in drug treatments as well as the occurrence of side-effects have been reported, leading to discontinuation of treatment or to progressive disease. Therefore, new drugs are needed to cure AE and CE. Strategies that are currently employed in order to identify novel chemotherapeutical treatment options include in vitro and in vivo testing of broad-spectrum anti-infective drugs or drugs that interfere with unlimited proliferation of cancer cells. The fact that the genome of E. multilocularis has recently been sequenced has opened other avenues, such as the selection of novel drugs that interfere with the parasite signalling machinery, and the application of in silico approaches by employing the Echinococcus genome information to search for suitable targets for compounds of known mode of action.


Subject(s)
Anthelmintics/therapeutic use , Anti-Infective Agents/therapeutic use , Antineoplastic Agents/therapeutic use , Echinococcosis/drug therapy , Animals , Cestoda/drug effects , Cestoda/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...